Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: Comparisons with tissue epoxide concentrations following low-level exposures

Toxicological Sciences

Volumn 41, Issue 2, 1998, Pages 167-173

  Thornton Manning, Janice R ^a,c   Dahl, Alan R ^a   Alien, Margo L ^b   Bechtold, William E ^b   Griffith Jr , William C ^a   Henderson, Rogene F ^b  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b PFIZER INC   (United States)

^c Inhalation Toxicology Research Institute   (United States)

Author keywords

1,3 butadiene; Butadiene diepoxide; Butadiene monoepoxide; Metabolism

Indexed keywords

1,3 BUTADIENE; 1,3 BUTADIENE DIEPOXIDE; 1,3 BUTADIENE MONOEPOXIDE; EPOXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; INHALATION; MAMMARY GLAND; NONHUMAN; RAT; RUBBER INDUSTRY; TISSUE LEVEL;

ANIMALIA;

EID: 0031896054     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1006/toxs.1997.2403     Document Type: Article

References (35)

1. Adler, I.-D., Cao, J., Fuser, J. G., Gassner, R, Kassier, W., Kliesch, U., Neuhauser-Klaus, A., and Nüsse, M. (1994). Mutagenicity of 1,3-butadiene inhalation in somatfc and germinal cells of mice. Mittat. Res. 309, 307-314.
2. Autio, K., Renzi, L., Catalan, J., Albrecht, O. E., and Sorsa, M. (1994). Induction of micronuclei in peripheral blood and bone marrow erythocytes of rats and mice exposed to 1,3-butadiene by inhalation. Mittat. Res. 30, 315-320.
3. Bechtold, W. E., Strunk, M. R., Thornton-Manning, J. R., and Henderson, R. F. (1995). Analysis of butadiene, butadiene monoxide and butadiene dioxide in blood by gas chromatography/gas chromatography/mass spectroscopy. Chem. Res. Toxicol. 8, 182-187.
4. Bolt, H. M., Filser, J. G., and Stornier, F. (1994). Inhalation pharmacokinetics based on gas uptake studies. V. Comparative pharmacokinetics of ethylene and 1,3-butadiene in rats. Arch. Toxicol. 55, 213-218.
5. Bolt, H. M., Schmiedel, G., Filser, J. G., Rolzhauser, H. P., Lieser, K., Wistuba, D., and Schurig, V. (1983). Biological activation of 1,3-butadiene to vinyl oxirane by rat liver microsomes and expiration of the reactive metabolite by exposed rats. J. Cancer Res. Clin. Oncol. 106, 112-116.
6. Bond, J. A., Dahl, A. R., Henderson, R. F., Dutcher, J. S., Mauderly, J. L., and Birnbaum, L. S. (1986). Species differences in the disposition of inhaled butadiene. Toxicol. Appl. Pharmacol. 84, 617-627.
7. Bond, J. A., Recio, L., and Andjelkovich, D. (1995). Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace. Carcinogenesis 16, 165-171.
8. Boogaard, P. J., Sumner, S. C.-J., and Bond, J. A. (1996). Glutathione conju-gation of 1,2,3,4-diepoxybutane in human liver and rat and mouse liver and lung m vitro. Toxicol. Appl. Pharmacol. 136, 307-316.
9. Csanddy, G. A., Guengerich, F. P., and Bond, J. A. (1992). Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 13, 1143-1153.
10. Chemical and Engineering News (1995). Production of top 50 chemicals increased substantially in 1994. Chem. Eng. News April 10, 16-20.
11. Choudary, G. (1994). Environmental exposure to 1,3-butadiene: A human health perspective. Environ. Carcinogen. Ecolox. Rev. C12, 23-61.
12. Cochrane, J. E., and Skopek, T. R. (1994). Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4diepoxybutane and 3,4-epoxy-l,2-butanediol in cultured human lymphoblasts. Carcinogenesis 15, 713-714.
13. Deuscher, R. J., and Elfarra, A. A. (1994). Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: Evidence of major roles by cytochrome P450 2A6 and 2E1. Arch. Biochem. Biophys. 311, 342-349.
14. Environmental Protection Agency (1991). Preliminary draft list of categories and subcategorizes under section 112 of the Clean Air Act. Fed. Keg. 56, 28548-28557.
15. Himmelstein, M. W., Turner, M. J., Asgharian, B., and Bond, J. A. (1996). Metabolism of 1,3-butadiene: Inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice. Toxicology 113, 306-309.
16. Himmelstein, M. W., Turner, M. J., Asgharian, B., and Bond, J. A. (1994). Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogenesis 15, 1473-1486.
17. Himmelstein, M. W., Asgharian, B., and Bond, J. A. (1995). High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene. Toxicol. App. Pharmacol. 132, 281-288.
18. Himmelstein, M. W., Acquavella, J. F., Recio, L., Medinsky, M. A., and Bond, J. A. (1997). Toxicology and epidemiology of 1,3-butadiene. CRC Crit. Rev. Toxicol. 27, 1-108.
19. 14C] 1,3-butadiene. Toxicol. Lett. 30, 131-136.
20. Malvoisin, E., and Roberfroid, M. (1982). Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica 12, 137-144.
21. Maples, K. R., Lane, J. L., and Dahl, A. R. (1992). An efficient method for synthesizing [d6]-butadiene monoepoxide. J. Labelled Compounds Radiophantmceiiticals 31, 469-475.
22. Medinsky, M. A., Leavens, T. L., Csanády, G. A., Gargas, M. L., and Bond, J. A. (1994). In vivo metabolism of butadiene by mice and rats: A comparison of physiological model predictions and experimental data. Carcinogenesis 15, 1329-1340.
23. Melnick, R. L., Huff, J., Chou, B. J., and Miller, R. A. (1990). Carcinogenicity of 1,3-butadiene in C57BL/6 X C3H Fl mice at low exposure concentrations. Cancer Res. 50, 6592-6599.
24. Miller, L. M. (1978). Investigation of Selected potential Environmental Contaminants: Butadiene and Its Oligomers. [EPA 560/2-78-008]
25. Norppa, H., Hirvonen, A., Jarventaus, H., Uuskula, M., Tasa, G., Ojajarvi, A., and Sorsa, M. (1995). Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange by diepoxybutane in cultured human lymphocytes. Carcinogenesis 16, 1261-1264.
26. Owen, P. E., Glaister, J. R., Gaunt, I. F., and Pullinger, D. H. (1987). Inhalation toxicity studies with 1,3-butadiene: 3 two year toxicity/carcinogenicity study in rats. Am. Ind. Hyg. Assoc. J. 48, 407-413.
27. Schmidt, U., and Loeser, E. (1985). Species differences in the formation of butadiene monoxide from 1,3-butadiene. Arch. Toxicol. 57, 222-225.
28. Seaton, M. J., Follansbee, M. H., and Bond, J. A. (1995). Oxidation of l,2-epoxy-3-butene to 1,2,3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis 16, 2287-2293.
29. Thornton-Manning, J. R., Dahl, A. R., Bechtold, W. E., Griffith, W. C., Jr., and Henderson, R. F. (1997). Comparison of the disposition of butadiene epoxides in Sprague-Dawley rats and B6C3F, mice following a single and repeated exposures to 1,3-butadiene via inhalation. Toxicology 123, 125-134.
30. Thornton-Manning, J. R., Dahl, A. R., Bechtold, W. E., and Henderson, R. F. (1996). Gender and species differences in the metabolism of 1,3-butadiene to butadiene monoepoxide and butadiene diepoxide in rodents following low-level inhalation exposures. Toxicology 113, 322325.
31. Thornton-Manning, J. R., Dahl, A. R., Bechtold, W. E., Griffith, W. C., Jr., and Henderson, R. F. (1995a). Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis 16, 1723-1731.
32. Thornton-Manning, J. R., Dahl, A. R., Bechtold, W. E., Griffith, W. C., Jr., Pei, L., and Henderson, R. F. (1995b). Gender differences in the metabolism of 1,3-butadiene in Sprague-Dawley rats following a low level inhalation exposure. Carcinogenesis 16, 2875-2878.
33. Uuskula, M., Jarventaus, H., Hirvonen, A., Sorsa, M., and Norppa, H. (1995). Influence of GSTM1 genotype on sister chromatid exchange induction by styrene-7,8-oxide and l,2-epoxy-3-butene in cultured human lymphocytes. Carcinogenesis 16, 947-950.
34. Voogd, C. E., van der Stel, J. J., and Jacobs, J. J. J. A. A. (1981). The mutagenic action of aliphatic epoxides. Mutat. Res. 89, 269-282.
35. Wiencke, J. K., Pemble, S., Ketterer, B., and Kelsey, K. (1995) Gene deletion of glutathione S-transferase T: Correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epid. Biomark. Prevent. 4,253-259.